Health Canada medical device cybersecurity guidance raises PKI stakes

At a glance

What this is: Health Canada’s pre-market guidance for medical device cybersecurity shifts the burden of trust to the design stage, with PKI, encryption, access controls, and verification built into development.

Why it matters: For IAM, PAM, and NHI teams, the message is that connected devices need governed identity, certificate, and access controls before they ship, not after they are deployed into clinical environments.

Context

Medical device cybersecurity is the discipline of securing connected clinical equipment, companion devices, and their links to back-end systems before those products are released. The guidance described here treats trust as a design requirement, not a later operational patch, which matters because device identity and access decisions often outlive the manufacturing cycle.

DigiCert’s article frames Health Canada’s pre-market guidance as a response to the growing number of connected devices in healthcare, from hospital equipment to consumer wearables that send data through phones and cloud services. That changes the governance problem for medical device manufacturers: secure authentication, encryption, and access control must be established during product planning and verification, not added after deployment.

Key questions

Q: How should manufacturers secure connected medical devices before release?

A: Manufacturers should treat device trust as a design requirement, not a post-launch fix. That means building in authenticated connections, encryption, role-bound access controls, and security testing during planning, verification, and validation so the device ships with a governed trust model rather than an assumed one.

Q: Why do connected medical devices create identity security risk for hospitals?

A: Because they combine long lifetimes, network connectivity, and clinical dependencies, which makes trust failures hard to see and expensive to contain. If a device can authenticate poorly, integrate widely, or remain unpatched at end of life, it can become both an entry point and a multiplier for operational disruption.

Q: What breaks when device access controls are not built into product design?

A: When access controls are deferred, configuration changes and privilege grants become easier to abuse once the device is deployed. That creates a gap between intended clinical use and actual administrative power, which can undermine authentication, tamper resistance, and the safety assumptions behind the device.

Q: Should healthcare teams rely on post-deployment patching for device security?

A: No. For connected medical devices, the core trust decisions need to be established before release and then maintained through lifecycle monitoring. Post-deployment patching cannot substitute for authenticated connections, certificate governance, or privilege boundaries that were never designed into the product.

Technical breakdown

PKI as the trust layer for connected medical devices

Public key infrastructure gives a device a cryptographic identity that back-end systems can verify before accepting data or control traffic. In practice, certificates and certificate authorities allow devices to prove they are legitimate, while encryption protects data in transit and, where implemented, data at rest. For healthcare, that matters because devices may connect to servers, electronic health record systems, tablets, phones, and cloud platforms. Without that trust layer, the connection itself becomes the weak point, not just the device software.

Practical implication: Use PKI to bind device identity to authenticated back-end communication and treat certificate lifecycle as part of product security.

Secure authentication and device access controls

The guidance emphasises secure authentication between devices and back-end systems, plus access controls that limit who can alter configuration or privileges. That is a governance issue as much as a technical one, because medical devices often sit in shared clinical environments where unauthorised changes can affect patient safety. Access control in this context is not just about user login. It also includes who can administer, reconfigure, or integrate the device into hospital systems. That is why identity scope must be explicit before deployment.

Practical implication: Define device administration roles and authentication paths before release, then verify that privilege boundaries match intended clinical use.

Verification, validation, and monitoring for emerging risk

Health Canada’s guidance ties security to the manufacturer’s verification and validation process, which means device security testing must be part of release readiness. This is more than a checklist: it requires checking whether the device resists configuration tampering, whether encryption is correctly implemented, and whether known interfaces expose unnecessary trust paths. The guidance also calls for monitoring and responding to emerging risks, which reflects the reality that connected medical devices remain exposed after shipment and may need security updates or operational controls across their lifecycle.

Practical implication: Include cybersecurity tests in V&V gates and maintain post-release monitoring for configuration drift and newly discovered exposure paths.

Threat narrative

Attacker objective: The objective is to gain unauthorised control of connected medical devices or their data flows in a way that compromises patient trust, operational integrity, or safety.

1. Entry begins when a connected medical device accepts insecure or weakly authenticated connections from other devices, applications, or back-end systems. In healthcare environments, that can create a foothold through routine integration rather than direct exploitation.
2. Escalation follows when an attacker or unauthorised user can alter device configuration, privilege settings, or data flows because access controls were not designed into the device lifecycle. That turns the device from a passive endpoint into a controllable system component.
3. Impact occurs when manipulated devices expose patient data, disrupt clinical workflows, or create safety risks in equipment that supports diagnosis, monitoring, or treatment. In healthcare, the security outcome can quickly become an operational and physical one.

Breaches seen in the wild

• GitHub code signing certificate theft 2022: A machine account's compromised token cloned GitHub's Desktop and Atom repos, exposing encrypted signing certificates later revoked.
• Sisense breach 2024: A credential in Sisense's GitLab reportedly opened S3 buckets of customer tokens, passwords and certificates; CISA urged a full reset.

Read and download The State of NHI & AI Agent Breach Report 2026, covering 150+ breaches impacting Non-Human Identities including AI Agents.

NHI Mgmt Group analysis

Pre-market device trust is now an identity governance problem, not just a product security issue. Health Canada’s guidance pushes manufacturers to prove that devices can authenticate, encrypt, and resist tampering before they reach the market. That moves the control point upstream into design, verification, and lifecycle governance. For practitioners, the important shift is that device identity must be treated like any other governed identity surface, with explicit trust boundaries before release.

PKI becomes the practical control plane for medical device trust. When devices connect to servers, EHR systems, tablets, phones, and cloud services, certificates and encrypted sessions are what separate legitimate integration from unmanaged exposure. That makes certificate issuance, renewal, and revocation part of device governance rather than an implementation detail. The implication is clear: if the certificate lifecycle is not owned, the device trust model is not owned either.

Access control inside a medical device is a clinical safety control. The article highlights the risk of unauthorised individuals changing configuration settings, which means privilege boundaries directly affect patient outcomes. That is why device admin access, back-end connectivity, and configuration authority need to be scoped deliberately. In healthcare, the device privilege model is not an IT convenience; it is part of the safety case.

Connected device governance must cover the full lifecycle, including post-release monitoring. Health Canada’s guidance recognises that emerging risks do not end at shipment, especially as devices connect through consumer phones, hospital systems, and cloud platforms. That means lifecycle thinking is mandatory for both manufacturers and healthcare operators. The practitioner conclusion is to govern devices as living identities with evolving exposure, not as static products once they leave the factory.

Medical device cybersecurity sits at the intersection of NHI, IAM, and operational resilience. The same governance logic used for workload identity and service credentials applies here: trust must be explicit, least privilege must be bounded, and off-path access must be constrained. What makes medical devices distinct is the safety impact when identity or access fails. For healthcare programmes, this is where security and patient safety stop being adjacent and become the same control problem.

What this signals

Connected device governance now extends into identity lifecycle decisions. Medical devices should be treated as governed endpoints with explicit authentication, privilege boundaries, and certificate ownership. That means healthcare organisations need procurement, security engineering, and clinical operations to align before devices are deployed into live environments.

Certificate trust is part of medical device safety engineering. When devices connect through EHR systems, tablets, phones, and cloud services, certificate failures become trust failures. The practical implication is that PKI, revocation, and validation cannot sit outside the device programme just because the asset is clinical rather than IT.

Lifecycle monitoring matters because medical devices do not become safe at shipment. The article’s focus on emerging risks reflects a broader pattern in connected healthcare: device exposure changes after deployment as integrations, networks, and usage models shift. Security teams should therefore govern devices across their full operational life, not only during procurement.

For practitioners

• Define device identity before release Assign each connected medical device a verifiable cryptographic identity and document how it will authenticate to approved back-end systems, including EHR and cloud services.
• Build certificate lifecycle into product governance Track issuance, renewal, revocation, and replacement of device certificates as part of the manufacturer’s security lifecycle, not as an afterthought for operations.
• Constrain configuration and privilege paths Limit who can change device settings, approve integrations, or grant elevated access, and test those boundaries during verification and validation.
• Add security testing to release gates Include checks for authentication strength, encryption use, and configuration tampering resistance in the formal verification and validation process before shipment.
• Monitor devices after deployment Establish a process to watch for emerging risks, newly exposed interfaces, and changes in the trust relationships that the device depends on in the field.

Key takeaways

• Health Canada’s guidance moves connected medical devices into a design-time trust model where authentication, encryption, and access control must be proven before release.
• For healthcare manufacturers, PKI is not optional plumbing. It is the mechanism that gives connected devices a verifiable identity and keeps back-end communications trustworthy.
• The governance lesson is broader than device hardening. Medical device programmes need lifecycle controls that cover release readiness, certificate management, and post-deployment monitoring.

Key terms

• Medical Device Security: Medical device security is the practice of protecting connected clinical equipment from unauthorized access, tampering, data exposure, and service disruption. It covers device firmware, communications, identity controls, patching, segmentation, logging, and lifecycle management so that patient safety, clinical availability, and regulated data integrity are preserved across hospitals, suppliers, and remote support channels.
• Public Key Infrastructure: Public Key Infrastructure is the trust system that issues, manages, and revokes digital certificates used to prove identity. In practice it binds keys to entities and policies, making authentication, encryption, and non-repudiation possible across users, devices, and services.
• Digital Certificate Lifecycle: The digital certificate lifecycle covers issuance, deployment, monitoring, renewal, revocation, and replacement. Each stage carries operational and security risk, so mature management requires visibility into where certificates are used and the ability to act quickly when trust conditions change.
• Verification and Validation: Verification and validation are the post-remediation checks that confirm a vulnerability has actually been fixed and the system still works as intended. Verification proves the corrective action closed the issue, while validation checks that no new instability, performance loss, or functional regression was introduced.

Deepen your knowledge

NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building or maturing an IAM programme, it is worth exploring.